News

EMPHNET Supports Training on Fluorescent Polarization Assay (FPA) for Diagnosis of Animal Brucellosis
    EMPHNET Supports Training on Fluorescent Polarization Assay (FPA) for Diagnosis of Animal Brucellosis
    November 19, 2018   |  Jordan

    EMPHNET, in collaboration with the Centers of Disease Control (CDC) and experts from Ellie LLC, conducted a three-day practical training on the use of Fluorescent Polarization Assay (FPA) as a rapid diagnostic test for brucellosis.

    Taking place between November 13 and 15, the training was conducted within three governorates in Jordan: East Amman, Karak, and Mafraq. Eight veterinarians from each veterinary directorate within these three governorates participated in this training. Its agenda comprised both didactic and practical sessions focusing on the use of the brucella diagnostic test Fluorescent Polarization Assay (FPA) to diagnose brucellosis in animals. This test presents a new field-based technique used to detect Brucella antibodies in serum and milk from suspected brucella animal cases.

    EMPHNET is introducing this new test for the first time within the Ministry of Agriculture (MoA) and the veterinary directorate. As part of this introduction, it will provide the directorates with four devices and kits necessary for the test.

    This training falls within a project titled “Evaluating the Impact of Enhanced Laboratory Based Surveillance of Animal and Human Brucellosis in Jordan.” This is a collaborative project implemented by EMPHNET, the CDC, the Ministry of Health (MoH), and the Ministry of Agriculture (MoA). Its aim is to perform active laboratory-based surveillance in the following three governorates in Jordan: East Amman, Karak, and Mafraq. The outcome of this project will be an improved understanding of the disease burden, mechanism of transmission between animals and humans, and its major risk factors.